Mirae Asset Global Investments Co. Ltd. boosted its stake in The Clorox Company (NYSE:CLX - Free Report) by 12.4% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,799 shares of the company's stock after buying an additional 2,291 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Clorox were worth $3,042,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of CLX. Redwood Park Advisors LLC acquired a new position in Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new position in shares of Clorox during the fourth quarter valued at approximately $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the fourth quarter worth approximately $31,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox in the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in Clorox in the 4th quarter valued at $33,000. Institutional investors and hedge funds own 78.53% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the company. Barclays lowered their price objective on Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research report on Wednesday, May 7th. UBS Group decreased their target price on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research report on Thursday, April 17th. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a research report on Tuesday, May 6th. Citigroup decreased their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Finally, Wells Fargo & Company dropped their price objective on Clorox from $145.00 to $142.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $149.50.
View Our Latest Research Report on Clorox
Clorox Stock Up 0.1%
Clorox stock traded up $0.14 during midday trading on Thursday, hitting $124.80. 1,078,076 shares of the stock were exchanged, compared to its average volume of 1,397,254. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The company has a 50 day moving average price of $130.17 and a two-hundred day moving average price of $144.40. The firm has a market cap of $15.38 billion, a P/E ratio of 22.41, a P/E/G ratio of 3.01 and a beta of 0.51. The Clorox Company has a 1 year low of $117.35 and a 1 year high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The company's revenue was down 8.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.71 EPS. On average, sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Insider Activity at Clorox
In related news, Director Pierre R. Breber purchased 4,000 shares of the firm's stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director owned 4,000 shares of the company's stock, valued at $546,280. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.57% of the company's stock.
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
